Nanomedicines demand tight control over particle properties, reproducibility, and scalability, yet conventional batch methods often struggle to deliver all three.
In this whitepaper, Ardena’s nanomedicines experts Mark van Eldijk and Andy Bänziger explore how flow manufacturing can enable more consistent nanoparticle production, simplify scale-up, and support robust development pathways from early-stage research through GMP manufacturing.
The paper includes a practical case study using a multi-inlet vortex mixer (MIVM) for liposome production, showing how key process parameters influence particle size and polydispersity.
Download the whitepaper to learn:
- Why flow manufacturing improves reproducibility compared to batch processes
- How continuous processing supports scalable nanoparticle production
- A real formulation case study demonstrating parameter-driven control
Get the whitepaper by filling in the form.
Thank you for your interest in our scientific content.
